Table 2.

Male subjects in whom 2 reportable variants were detected (all with hemophilia A)

Baseline level (%)First variant HGVS cDNAFirst variant exon/intronFirst variant HGVS proteinSecond variant HGVS cDNASecond variant exon/intronSecond variant HGVS protein
<1* c.6429+?_6430-?inv Intron 22 (F8 inversion) c.6188-?_6429+?del Exons 21-22 (Deletion) 
<1 c.6429+?_6430-?inv Intron 22 (F8 inversion) c.1908delGinsCATCAAAGTACTTCAAAAA Exon 17 p.Trp1908delinsSerSerLysTyrPheLysLys 
<1 c.6429+?_6430-?inv Intron 22 (F8 inversion) c.-279C>T 5′UTR NA 
<1 c.6429+?_6430-?inv Intron 22 (F8 inversion) c.6929C>T Exon 26 p.Thr2291Ile 
<1 c.6429+?_6430-?inv Intron 22 (F8 inversion) c.1-?_6429+?del Exons 1-22 (Deletion) 
<1 c.6429+?_6430-?inv Intron 22 (F8 inversion) c.6430-?_6900+?dup Exons 23-25 (Duplication) 
<1 c.6429+?_6430-?inv Intron 22 (F8 inversion) c.6116-?_6429+?del Exons 20-22 (Deletion) 
<1 c.1139A>G Exon 8 p.Asp380Gly c.5999-3_6002del Intron 18/exon 19 Gly2000Valfs*29 
<1 c.1313T>C Exon 9 p.Ile438Thr c.1373G>A Exon 9 Arg458His 
<1 c.144-?_601+?dup§ Exons 2-4 (Duplication) c.671-?_787+?dup§ Exon 6 (Duplication) 
<1 c.1538-18G>A§ Intron 10 (Splice) c.1538-13delT§ Intron 10 (Splice) 
<1 c.311T>G Exon 3 p.Val104Gly c.343G>C Intron 3 p.Val115Leu 
<1 c.389-?_1443+?del Exons 4-9 (Deletion) c.1538-?_1903+?del Exons 11-12 (Deletion) 
<1 c.5705T>G Exon 17 p.Phe1902Cys c.5725T>C Exon 17 p.Tyr1909His 
<1 c.575T>C Exon 4 p.Ile192Thr c.589G>C Exon 4 p.Val197Leu 
<1 c.5901C>G Exon 18 p.(=) c.5921C>A Exon 18 p.Ser1974Tyr 
<1 c.6406C>T Exon 19 p.Arg2016Trp c.6724G>A Exon 25 p.Val2242Met 
<1 c.6046C>T Exon 19 p.Arg2016Trp c.6403C>T Exon 22 p.Arg2135* 
c.5247C>G Exon 15 p.Phe1749Leu c.5302C>T Exon 15 Arg1768Cys 
c.1280A>T Exon 9 p.Lys427Ile c.1309C>T Exon 9 p.Arg437Trp 
22 c.655G>A Exon 5 p.Ala219Thr c.6583C>A Exon 24 p.Met2195Leu 
Baseline level (%)First variant HGVS cDNAFirst variant exon/intronFirst variant HGVS proteinSecond variant HGVS cDNASecond variant exon/intronSecond variant HGVS protein
<1* c.6429+?_6430-?inv Intron 22 (F8 inversion) c.6188-?_6429+?del Exons 21-22 (Deletion) 
<1 c.6429+?_6430-?inv Intron 22 (F8 inversion) c.1908delGinsCATCAAAGTACTTCAAAAA Exon 17 p.Trp1908delinsSerSerLysTyrPheLysLys 
<1 c.6429+?_6430-?inv Intron 22 (F8 inversion) c.-279C>T 5′UTR NA 
<1 c.6429+?_6430-?inv Intron 22 (F8 inversion) c.6929C>T Exon 26 p.Thr2291Ile 
<1 c.6429+?_6430-?inv Intron 22 (F8 inversion) c.1-?_6429+?del Exons 1-22 (Deletion) 
<1 c.6429+?_6430-?inv Intron 22 (F8 inversion) c.6430-?_6900+?dup Exons 23-25 (Duplication) 
<1 c.6429+?_6430-?inv Intron 22 (F8 inversion) c.6116-?_6429+?del Exons 20-22 (Deletion) 
<1 c.1139A>G Exon 8 p.Asp380Gly c.5999-3_6002del Intron 18/exon 19 Gly2000Valfs*29 
<1 c.1313T>C Exon 9 p.Ile438Thr c.1373G>A Exon 9 Arg458His 
<1 c.144-?_601+?dup§ Exons 2-4 (Duplication) c.671-?_787+?dup§ Exon 6 (Duplication) 
<1 c.1538-18G>A§ Intron 10 (Splice) c.1538-13delT§ Intron 10 (Splice) 
<1 c.311T>G Exon 3 p.Val104Gly c.343G>C Intron 3 p.Val115Leu 
<1 c.389-?_1443+?del Exons 4-9 (Deletion) c.1538-?_1903+?del Exons 11-12 (Deletion) 
<1 c.5705T>G Exon 17 p.Phe1902Cys c.5725T>C Exon 17 p.Tyr1909His 
<1 c.575T>C Exon 4 p.Ile192Thr c.589G>C Exon 4 p.Val197Leu 
<1 c.5901C>G Exon 18 p.(=) c.5921C>A Exon 18 p.Ser1974Tyr 
<1 c.6406C>T Exon 19 p.Arg2016Trp c.6724G>A Exon 25 p.Val2242Met 
<1 c.6046C>T Exon 19 p.Arg2016Trp c.6403C>T Exon 22 p.Arg2135* 
c.5247C>G Exon 15 p.Phe1749Leu c.5302C>T Exon 15 Arg1768Cys 
c.1280A>T Exon 9 p.Lys427Ile c.1309C>T Exon 9 p.Arg437Trp 
22 c.655G>A Exon 5 p.Ala219Thr c.6583C>A Exon 24 p.Met2195Leu 

HGVS, Human Genome Variation Society; NA, not available.

*

Subject also had c.2114-?_5219+?_del, which results in deletion of exon 14.

If exon 19 is transcribed.

Found in 3 subjects with same 3 variants.

§

Found in 2 subjects with same 2 variants.

Close Modal

or Create an Account

Close Modal
Close Modal